Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
J Allergy Clin Immunol. 2019 May;143(5):1803-1810.e2. doi: 10.1016/j.jaci.2018.09.037. Epub 2018 Dec 13.
Asthma phenotypes are currently not amenable to primary prevention or early intervention because their natural history cannot be reliably predicted. Clinicians remain reliant on poorly predictive asthma outcome tools because of a lack of better alternatives.
We sought to develop a quantitative personalized tool to predict asthma development in young children.
Data from the Cincinnati Childhood Allergy and Air Pollution Study (n = 762) birth cohort were used to identify factors that predicted asthma development. The Pediatric Asthma Risk Score (PARS) was constructed by integrating demographic and clinical data. The sensitivity and specificity of PARS were compared with those of the Asthma Predictive Index (API) and replicated in the Isle of Wight birth cohort.
PARS reliably predicted asthma development in the Cincinnati Childhood Allergy and Air Pollution Study (sensitivity = 0.68, specificity = 0.77). Although both the PARS and API predicted asthma in high-risk children, the PARS had improved ability to predict asthma in children with mild-to-moderate asthma risk. In addition to parental asthma, eczema, and wheezing apart from colds, variables that predicted asthma in the PARS included early wheezing (odds ratio [OR], 2.88; 95% CI, 1.52-5.37), sensitization to 2 or more food allergens and/or aeroallergens (OR, 2.44; 95% CI, 1.49-4.05), and African American race (OR, 2.04; 95% CI, 1.19-3.47). The PARS was replicated in the Isle of Wight birth cohort (sensitivity = 0.67, specificity = 0.79), demonstrating that it is a robust, valid, and generalizable asthma predictive tool.
The PARS performed better than the API in children with mild-to-moderate asthma. This is significant because these children are the most common and most difficult to predict and might be the most amenable to prevention strategies.
目前,哮喘表型不能进行主要预防或早期干预,因为其自然史无法可靠预测。由于缺乏更好的替代方法,临床医生仍然依赖预测效果不佳的哮喘结局工具。
我们试图开发一种定量的个性化工具来预测幼儿哮喘的发展。
使用辛辛那提儿童过敏和空气污染研究(n=762)的出生队列数据来确定预测哮喘发展的因素。通过整合人口统计学和临床数据来构建儿科哮喘风险评分(PARS)。将 PARS 的敏感性和特异性与哮喘预测指数(API)进行比较,并在怀特岛出生队列中进行复制。
PARS 能够可靠地预测辛辛那提儿童过敏和空气污染研究中的哮喘发展(敏感性=0.68,特异性=0.77)。尽管 PARS 和 API 都能预测高危儿童的哮喘,但 PARS 能够更好地预测哮喘风险处于轻度至中度的儿童的哮喘。除了父母哮喘、湿疹和感冒以外的喘息外,PARS 中预测哮喘的变量还包括早期喘息(优势比[OR],2.88;95%置信区间[CI],1.52-5.37)、对 2 种或更多食物过敏原和/或空气过敏原致敏(OR,2.44;95% CI,1.49-4.05)以及非裔美国人种族(OR,2.04;95% CI,1.19-3.47)。PARS 在怀特岛出生队列中得到了复制(敏感性=0.67,特异性=0.79),这表明它是一种可靠、有效且可推广的哮喘预测工具。
在哮喘处于轻度至中度的儿童中,PARS 的表现优于 API。这很重要,因为这些儿童是最常见且最难预测的,并且可能最适合预防策略。